Global Celecoxib Market Research Report 2026(Status and Outlook)
Celecoxib capsules (patent brand name: CELEBREX), is a new generation of non-steroidal anti-inflammatory and analgesic drugs, mainly through the selective inhibition of coX-2 (COX-2) to inhibit the production of prostaglandins, achieve anti-inflammatory and analgesic effects.The drug is used to relieve symptoms and signs of osteoarthritis and rheumatoid arthritis in adults and has fewer gastrointestinal side effects than traditional non-steroidal anti-inflammatory drugs.Data show that more than 400 million people worldwide are currently affected by joint diseases.The prevalence of osteoarthritis is 17 percent among people aged 40, 62 percent among people over 60 and 80 percent among people over 75.The number of patients with arthritis in mainland China is more than 10% of the total population, well over 100 million, and the incidence of arthritis increases with age, and the number of patients is still increasing.At present, the burden of chronic diseases will increase by 40% due to the aging of the population.As the population ages, anti-inflammatory and anti-rheumatic drugs will enter a phase of rapid growth.Globally, whether prescription drugs or non-prescription drugs, Xibu is widely used in clinical practice.At present, the best seller in the international market is Celixib. Celixib market will continue to grow steadily in the next few years.At present, the global Celecoxib market is basically occupied by Pfizer, which has formed an oligopoly.It accounted for 63.39% of the global market in 2019.As of 2019, China relies entirely on Pfizer for celecoxib imports.Since 2020, some domestic drug companies have been gradually approved by FDA and CFDA. The introduction of celecoxib generic drugs by local companies will break the monopoly of import.
The global Celecoxib market size was estimated at USD 1492.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 8.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Celecoxib market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Celecoxib market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Celecoxib market.
Global Celecoxib Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Pfizer Inc
Teva
Mylan
Apotex
Lupin
Hengrui Medicine
Market Segmentation (by Type)
50mg
100mg
200mg
400mg
Market Segmentation (by Application)
Rheumatoid arthritis
osteoarthritis
Acute pain
Musculoskeletal pain
Other diseases
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Celecoxib Market
Overview of the regional outlook of the Celecoxib Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Celecoxib Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Celecoxib, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Celecoxib market size was estimated at USD 1492.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 8.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Celecoxib market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Celecoxib market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Celecoxib market.
Global Celecoxib Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Pfizer Inc
Teva
Mylan
Apotex
Lupin
Hengrui Medicine
Market Segmentation (by Type)
50mg
100mg
200mg
400mg
Market Segmentation (by Application)
Rheumatoid arthritis
osteoarthritis
Acute pain
Musculoskeletal pain
Other diseases
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Celecoxib Market
Overview of the regional outlook of the Celecoxib Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Celecoxib Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Celecoxib, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Celecoxib
1.2 Key Market Segments
1.2.1 Celecoxib Segment by Type
1.2.2 Celecoxib Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELECOXIB MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Celecoxib Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Celecoxib Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELECOXIB MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Celecoxib Product Life Cycle
3.3 Global Celecoxib Sales by Manufacturers (2020-2025)
3.4 Global Celecoxib Revenue Market Share by Manufacturers (2020-2025)
3.5 Celecoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Celecoxib Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Celecoxib Market Competitive Situation and Trends
3.8.1 Celecoxib Market Concentration Rate
3.8.2 Global 5 and 10 Largest Celecoxib Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CELECOXIB INDUSTRY CHAIN ANALYSIS
4.1 Celecoxib Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELECOXIB MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Celecoxib Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Celecoxib Market
5.7 ESG Ratings of Leading Companies
6 CELECOXIB MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Celecoxib Sales Market Share by Type (2020-2025)
6.3 Global Celecoxib Market Size by Type (2020-2025)
6.4 Global Celecoxib Price by Type (2020-2025)
7 CELECOXIB MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Celecoxib Market Sales by Application (2020-2025)
7.3 Global Celecoxib Market Size (M USD) by Application (2020-2025)
7.4 Global Celecoxib Sales Growth Rate by Application (2020-2025)
8 CELECOXIB MARKET SALES BY REGION
8.1 Global Celecoxib Sales by Region
8.1.1 Global Celecoxib Sales by Region
8.1.2 Global Celecoxib Sales Market Share by Region
8.2 Global Celecoxib Market Size by Region
8.2.1 Global Celecoxib Market Size by Region
8.2.2 Global Celecoxib Market Size by Region
8.3 North America
8.3.1 North America Celecoxib Sales by Country
8.3.2 North America Celecoxib Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Celecoxib Sales by Country
8.4.2 Europe Celecoxib Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Celecoxib Sales by Region
8.5.2 Asia Pacific Celecoxib Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Celecoxib Sales by Country
8.6.2 South America Celecoxib Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Celecoxib Sales by Region
8.7.2 Middle East and Africa Celecoxib Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CELECOXIB MARKET PRODUCTION BY REGION
9.1 Global Production of Celecoxib by Region(2020-2025)
9.2 Global Celecoxib Revenue Market Share by Region (2020-2025)
9.3 Global Celecoxib Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Celecoxib Production
9.4.1 North America Celecoxib Production Growth Rate (2020-2025)
9.4.2 North America Celecoxib Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Celecoxib Production
9.5.1 Europe Celecoxib Production Growth Rate (2020-2025)
9.5.2 Europe Celecoxib Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Celecoxib Production (2020-2025)
9.6.1 Japan Celecoxib Production Growth Rate (2020-2025)
9.6.2 Japan Celecoxib Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Celecoxib Production (2020-2025)
9.7.1 China Celecoxib Production Growth Rate (2020-2025)
9.7.2 China Celecoxib Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pfizer Inc
10.1.1 Pfizer Inc Basic Information
10.1.2 Pfizer Inc Celecoxib Product Overview
10.1.3 Pfizer Inc Celecoxib Product Market Performance
10.1.4 Pfizer Inc Business Overview
10.1.5 Pfizer Inc SWOT Analysis
10.1.6 Pfizer Inc Recent Developments
10.2 Teva
10.2.1 Teva Basic Information
10.2.2 Teva Celecoxib Product Overview
10.2.3 Teva Celecoxib Product Market Performance
10.2.4 Teva Business Overview
10.2.5 Teva SWOT Analysis
10.2.6 Teva Recent Developments
10.3 Mylan
10.3.1 Mylan Basic Information
10.3.2 Mylan Celecoxib Product Overview
10.3.3 Mylan Celecoxib Product Market Performance
10.3.4 Mylan Business Overview
10.3.5 Mylan SWOT Analysis
10.3.6 Mylan Recent Developments
10.4 Apotex
10.4.1 Apotex Basic Information
10.4.2 Apotex Celecoxib Product Overview
10.4.3 Apotex Celecoxib Product Market Performance
10.4.4 Apotex Business Overview
10.4.5 Apotex Recent Developments
10.5 Lupin
10.5.1 Lupin Basic Information
10.5.2 Lupin Celecoxib Product Overview
10.5.3 Lupin Celecoxib Product Market Performance
10.5.4 Lupin Business Overview
10.5.5 Lupin Recent Developments
10.6 Hengrui Medicine
10.6.1 Hengrui Medicine Basic Information
10.6.2 Hengrui Medicine Celecoxib Product Overview
10.6.3 Hengrui Medicine Celecoxib Product Market Performance
10.6.4 Hengrui Medicine Business Overview
10.6.5 Hengrui Medicine Recent Developments
11 CELECOXIB MARKET FORECAST BY REGION
11.1 Global Celecoxib Market Size Forecast
11.2 Global Celecoxib Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Celecoxib Market Size Forecast by Country
11.2.3 Asia Pacific Celecoxib Market Size Forecast by Region
11.2.4 South America Celecoxib Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Celecoxib by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Celecoxib Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Celecoxib by Type (2026-2035)
12.1.2 Global Celecoxib Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Celecoxib by Type (2026-2035)
12.2 Global Celecoxib Market Forecast by Application (2026-2035)
12.2.1 Global Celecoxib Sales (K MT) Forecast by Application
12.2.2 Global Celecoxib Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Celecoxib
1.2 Key Market Segments
1.2.1 Celecoxib Segment by Type
1.2.2 Celecoxib Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELECOXIB MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Celecoxib Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Celecoxib Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELECOXIB MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Celecoxib Product Life Cycle
3.3 Global Celecoxib Sales by Manufacturers (2020-2025)
3.4 Global Celecoxib Revenue Market Share by Manufacturers (2020-2025)
3.5 Celecoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Celecoxib Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Celecoxib Market Competitive Situation and Trends
3.8.1 Celecoxib Market Concentration Rate
3.8.2 Global 5 and 10 Largest Celecoxib Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CELECOXIB INDUSTRY CHAIN ANALYSIS
4.1 Celecoxib Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELECOXIB MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Celecoxib Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Celecoxib Market
5.7 ESG Ratings of Leading Companies
6 CELECOXIB MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Celecoxib Sales Market Share by Type (2020-2025)
6.3 Global Celecoxib Market Size by Type (2020-2025)
6.4 Global Celecoxib Price by Type (2020-2025)
7 CELECOXIB MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Celecoxib Market Sales by Application (2020-2025)
7.3 Global Celecoxib Market Size (M USD) by Application (2020-2025)
7.4 Global Celecoxib Sales Growth Rate by Application (2020-2025)
8 CELECOXIB MARKET SALES BY REGION
8.1 Global Celecoxib Sales by Region
8.1.1 Global Celecoxib Sales by Region
8.1.2 Global Celecoxib Sales Market Share by Region
8.2 Global Celecoxib Market Size by Region
8.2.1 Global Celecoxib Market Size by Region
8.2.2 Global Celecoxib Market Size by Region
8.3 North America
8.3.1 North America Celecoxib Sales by Country
8.3.2 North America Celecoxib Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Celecoxib Sales by Country
8.4.2 Europe Celecoxib Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Celecoxib Sales by Region
8.5.2 Asia Pacific Celecoxib Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Celecoxib Sales by Country
8.6.2 South America Celecoxib Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Celecoxib Sales by Region
8.7.2 Middle East and Africa Celecoxib Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CELECOXIB MARKET PRODUCTION BY REGION
9.1 Global Production of Celecoxib by Region(2020-2025)
9.2 Global Celecoxib Revenue Market Share by Region (2020-2025)
9.3 Global Celecoxib Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Celecoxib Production
9.4.1 North America Celecoxib Production Growth Rate (2020-2025)
9.4.2 North America Celecoxib Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Celecoxib Production
9.5.1 Europe Celecoxib Production Growth Rate (2020-2025)
9.5.2 Europe Celecoxib Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Celecoxib Production (2020-2025)
9.6.1 Japan Celecoxib Production Growth Rate (2020-2025)
9.6.2 Japan Celecoxib Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Celecoxib Production (2020-2025)
9.7.1 China Celecoxib Production Growth Rate (2020-2025)
9.7.2 China Celecoxib Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pfizer Inc
10.1.1 Pfizer Inc Basic Information
10.1.2 Pfizer Inc Celecoxib Product Overview
10.1.3 Pfizer Inc Celecoxib Product Market Performance
10.1.4 Pfizer Inc Business Overview
10.1.5 Pfizer Inc SWOT Analysis
10.1.6 Pfizer Inc Recent Developments
10.2 Teva
10.2.1 Teva Basic Information
10.2.2 Teva Celecoxib Product Overview
10.2.3 Teva Celecoxib Product Market Performance
10.2.4 Teva Business Overview
10.2.5 Teva SWOT Analysis
10.2.6 Teva Recent Developments
10.3 Mylan
10.3.1 Mylan Basic Information
10.3.2 Mylan Celecoxib Product Overview
10.3.3 Mylan Celecoxib Product Market Performance
10.3.4 Mylan Business Overview
10.3.5 Mylan SWOT Analysis
10.3.6 Mylan Recent Developments
10.4 Apotex
10.4.1 Apotex Basic Information
10.4.2 Apotex Celecoxib Product Overview
10.4.3 Apotex Celecoxib Product Market Performance
10.4.4 Apotex Business Overview
10.4.5 Apotex Recent Developments
10.5 Lupin
10.5.1 Lupin Basic Information
10.5.2 Lupin Celecoxib Product Overview
10.5.3 Lupin Celecoxib Product Market Performance
10.5.4 Lupin Business Overview
10.5.5 Lupin Recent Developments
10.6 Hengrui Medicine
10.6.1 Hengrui Medicine Basic Information
10.6.2 Hengrui Medicine Celecoxib Product Overview
10.6.3 Hengrui Medicine Celecoxib Product Market Performance
10.6.4 Hengrui Medicine Business Overview
10.6.5 Hengrui Medicine Recent Developments
11 CELECOXIB MARKET FORECAST BY REGION
11.1 Global Celecoxib Market Size Forecast
11.2 Global Celecoxib Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Celecoxib Market Size Forecast by Country
11.2.3 Asia Pacific Celecoxib Market Size Forecast by Region
11.2.4 South America Celecoxib Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Celecoxib by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Celecoxib Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Celecoxib by Type (2026-2035)
12.1.2 Global Celecoxib Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Celecoxib by Type (2026-2035)
12.2 Global Celecoxib Market Forecast by Application (2026-2035)
12.2.1 Global Celecoxib Sales (K MT) Forecast by Application
12.2.2 Global Celecoxib Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Celecoxib Market Size by Type (M USD)
Table 4. Global Celecoxib Market Size by Application
Table 5. Celecoxib Market Size Comparison by Region (M USD)
Table 6. Global Celecoxib Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Celecoxib Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Celecoxib Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Celecoxib Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celecoxib as of 2025)
Table 11. Global Market Celecoxib Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Celecoxib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Celecoxib Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Celecoxib Sales by Type (K MT)
Table 27. Global Celecoxib Market Size by Type (M USD)
Table 28. Global Celecoxib Sales (K MT) by Type (2020-2025)
Table 29. Global Celecoxib Sales Market Share by Type (2020-2025)
Table 30. Global Celecoxib Market Size (M USD) by Type (2020-2025)
Table 31. Global Celecoxib Market Share by Type (2020-2025)
Table 32. Global Celecoxib Price (USD/KG) by Type (2020-2025)
Table 33. Global Celecoxib Sales (K MT) by Application
Table 34. Global Celecoxib Market Size by Application
Table 35. Global Celecoxib Sales by Application (2020-2025) & (K MT)
Table 36. Global Celecoxib Sales Market Share by Application (2020-2025)
Table 37. Global Celecoxib Market Size by Application (2020-2025) & (M USD)
Table 38. Global Celecoxib Market Share by Application (2020-2025)
Table 39. Global Celecoxib Sales Growth Rate by Application (2020-2025)
Table 40. Global Celecoxib Sales by Region (2020-2025) & (K MT)
Table 41. Global Celecoxib Sales Market Share by Region (2020-2025)
Table 42. Global Celecoxib Market Size by Region (2020-2025) & (M USD)
Table 43. Global Celecoxib Market Size by Region (2020-2025)
Table 44. North America Celecoxib Sales by Country (2020-2025) & (K MT)
Table 45. North America Celecoxib Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Celecoxib Sales by Country (2020-2025) & (K MT)
Table 47. Europe Celecoxib Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Celecoxib Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Celecoxib Market Size by Region (2020-2025) & (M USD)
Table 50. South America Celecoxib Sales by Country (2020-2025) & (K MT)
Table 51. South America Celecoxib Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Celecoxib Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Celecoxib Market Size by Region (2020-2025) & (M USD)
Table 54. Global Celecoxib Production (K MT) by Region(2020-2025)
Table 55. Global Celecoxib Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Celecoxib Revenue Market Share by Region (2020-2025)
Table 57. Global Celecoxib Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Celecoxib Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Celecoxib Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Celecoxib Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Celecoxib Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Pfizer Inc Basic Information
Table 63. Pfizer Inc Celecoxib Product Overview
Table 64. Pfizer Inc Celecoxib Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Pfizer Inc Business Overview
Table 66. Pfizer Inc SWOT Analysis
Table 67. Pfizer Inc Recent Developments
Table 68. Teva Basic Information
Table 69. Teva Celecoxib Product Overview
Table 70. Teva Celecoxib Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Teva Business Overview
Table 72. Teva SWOT Analysis
Table 73. Teva Recent Developments
Table 74. Mylan Basic Information
Table 75. Mylan Celecoxib Product Overview
Table 76. Mylan Celecoxib Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Mylan Business Overview
Table 78. Mylan SWOT Analysis
Table 79. Mylan Recent Developments
Table 80. Apotex Basic Information
Table 81. Apotex Celecoxib Product Overview
Table 82. Apotex Celecoxib Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Apotex Business Overview
Table 84. Apotex Recent Developments
Table 85. Lupin Basic Information
Table 86. Lupin Celecoxib Product Overview
Table 87. Lupin Celecoxib Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Lupin Business Overview
Table 89. Lupin Recent Developments
Table 90. Hengrui Medicine Basic Information
Table 91. Hengrui Medicine Celecoxib Product Overview
Table 92. Hengrui Medicine Celecoxib Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Hengrui Medicine Business Overview
Table 94. Hengrui Medicine Recent Developments
Table 95. Global Celecoxib Sales Forecast by Region (2026-2035) & (K MT)
Table 96. Global Celecoxib Market Size Forecast by Region (2026-2035) & (M USD)
Table 97. North America Celecoxib Sales Forecast by Country (2026-2035) & (K MT)
Table 98. North America Celecoxib Market Size Forecast by Country (2026-2035) & (M USD)
Table 99. Europe Celecoxib Sales Forecast by Country (2026-2035) & (K MT)
Table 100. Europe Celecoxib Market Size Forecast by Country (2026-2035) & (M USD)
Table 101. Asia Pacific Celecoxib Sales Forecast by Region (2026-2035) & (K MT)
Table 102. Asia Pacific Celecoxib Market Size Forecast by Region (2026-2035) & (M USD)
Table 103. South America Celecoxib Sales Forecast by Country (2026-2035) & (K MT)
Table 104. South America Celecoxib Market Size Forecast by Country (2026-2035) & (M USD)
Table 105. Middle East and Africa Celecoxib Sales Forecast by Country (2026-2035) & (Units)
Table 106. Middle East and Africa Celecoxib Market Size Forecast by Country (2026-2035) & (M USD)
Table 107. Global Celecoxib Sales Forecast by Type (2026-2035) & (K MT)
Table 108. Global Celecoxib Market Size Forecast by Type (2026-2035) & (M USD)
Table 109. Global Celecoxib Price Forecast by Type (2026-2035) & (USD/KG)
Table 110. Global Celecoxib Sales (K MT) Forecast by Application (2026-2035)
Table 111. Global Celecoxib Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Celecoxib Market Size by Type (M USD)
Table 4. Global Celecoxib Market Size by Application
Table 5. Celecoxib Market Size Comparison by Region (M USD)
Table 6. Global Celecoxib Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Celecoxib Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Celecoxib Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Celecoxib Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celecoxib as of 2025)
Table 11. Global Market Celecoxib Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Celecoxib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Celecoxib Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Celecoxib Sales by Type (K MT)
Table 27. Global Celecoxib Market Size by Type (M USD)
Table 28. Global Celecoxib Sales (K MT) by Type (2020-2025)
Table 29. Global Celecoxib Sales Market Share by Type (2020-2025)
Table 30. Global Celecoxib Market Size (M USD) by Type (2020-2025)
Table 31. Global Celecoxib Market Share by Type (2020-2025)
Table 32. Global Celecoxib Price (USD/KG) by Type (2020-2025)
Table 33. Global Celecoxib Sales (K MT) by Application
Table 34. Global Celecoxib Market Size by Application
Table 35. Global Celecoxib Sales by Application (2020-2025) & (K MT)
Table 36. Global Celecoxib Sales Market Share by Application (2020-2025)
Table 37. Global Celecoxib Market Size by Application (2020-2025) & (M USD)
Table 38. Global Celecoxib Market Share by Application (2020-2025)
Table 39. Global Celecoxib Sales Growth Rate by Application (2020-2025)
Table 40. Global Celecoxib Sales by Region (2020-2025) & (K MT)
Table 41. Global Celecoxib Sales Market Share by Region (2020-2025)
Table 42. Global Celecoxib Market Size by Region (2020-2025) & (M USD)
Table 43. Global Celecoxib Market Size by Region (2020-2025)
Table 44. North America Celecoxib Sales by Country (2020-2025) & (K MT)
Table 45. North America Celecoxib Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Celecoxib Sales by Country (2020-2025) & (K MT)
Table 47. Europe Celecoxib Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Celecoxib Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Celecoxib Market Size by Region (2020-2025) & (M USD)
Table 50. South America Celecoxib Sales by Country (2020-2025) & (K MT)
Table 51. South America Celecoxib Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Celecoxib Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Celecoxib Market Size by Region (2020-2025) & (M USD)
Table 54. Global Celecoxib Production (K MT) by Region(2020-2025)
Table 55. Global Celecoxib Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Celecoxib Revenue Market Share by Region (2020-2025)
Table 57. Global Celecoxib Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Celecoxib Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Celecoxib Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Celecoxib Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Celecoxib Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Pfizer Inc Basic Information
Table 63. Pfizer Inc Celecoxib Product Overview
Table 64. Pfizer Inc Celecoxib Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Pfizer Inc Business Overview
Table 66. Pfizer Inc SWOT Analysis
Table 67. Pfizer Inc Recent Developments
Table 68. Teva Basic Information
Table 69. Teva Celecoxib Product Overview
Table 70. Teva Celecoxib Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Teva Business Overview
Table 72. Teva SWOT Analysis
Table 73. Teva Recent Developments
Table 74. Mylan Basic Information
Table 75. Mylan Celecoxib Product Overview
Table 76. Mylan Celecoxib Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Mylan Business Overview
Table 78. Mylan SWOT Analysis
Table 79. Mylan Recent Developments
Table 80. Apotex Basic Information
Table 81. Apotex Celecoxib Product Overview
Table 82. Apotex Celecoxib Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Apotex Business Overview
Table 84. Apotex Recent Developments
Table 85. Lupin Basic Information
Table 86. Lupin Celecoxib Product Overview
Table 87. Lupin Celecoxib Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Lupin Business Overview
Table 89. Lupin Recent Developments
Table 90. Hengrui Medicine Basic Information
Table 91. Hengrui Medicine Celecoxib Product Overview
Table 92. Hengrui Medicine Celecoxib Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Hengrui Medicine Business Overview
Table 94. Hengrui Medicine Recent Developments
Table 95. Global Celecoxib Sales Forecast by Region (2026-2035) & (K MT)
Table 96. Global Celecoxib Market Size Forecast by Region (2026-2035) & (M USD)
Table 97. North America Celecoxib Sales Forecast by Country (2026-2035) & (K MT)
Table 98. North America Celecoxib Market Size Forecast by Country (2026-2035) & (M USD)
Table 99. Europe Celecoxib Sales Forecast by Country (2026-2035) & (K MT)
Table 100. Europe Celecoxib Market Size Forecast by Country (2026-2035) & (M USD)
Table 101. Asia Pacific Celecoxib Sales Forecast by Region (2026-2035) & (K MT)
Table 102. Asia Pacific Celecoxib Market Size Forecast by Region (2026-2035) & (M USD)
Table 103. South America Celecoxib Sales Forecast by Country (2026-2035) & (K MT)
Table 104. South America Celecoxib Market Size Forecast by Country (2026-2035) & (M USD)
Table 105. Middle East and Africa Celecoxib Sales Forecast by Country (2026-2035) & (Units)
Table 106. Middle East and Africa Celecoxib Market Size Forecast by Country (2026-2035) & (M USD)
Table 107. Global Celecoxib Sales Forecast by Type (2026-2035) & (K MT)
Table 108. Global Celecoxib Market Size Forecast by Type (2026-2035) & (M USD)
Table 109. Global Celecoxib Price Forecast by Type (2026-2035) & (USD/KG)
Table 110. Global Celecoxib Sales (K MT) Forecast by Application (2026-2035)
Table 111. Global Celecoxib Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Celecoxib
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Celecoxib Market Size (M USD), 2025-2035
Figure 5. Global Celecoxib Market Size (M USD) (2020-2035)
Figure 6. Global Celecoxib Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Celecoxib Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Celecoxib Product Life Cycle
Figure 13. Celecoxib Sales Share by Manufacturers in 2025
Figure 14. Global Celecoxib Revenue Share by Manufacturers in 2025
Figure 15. Celecoxib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Celecoxib Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Celecoxib Revenue in 2025
Figure 18. Industry Chain Map of Celecoxib
Figure 19. Global Celecoxib Market PEST Analysis
Figure 20. Global Celecoxib Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Celecoxib Market Share by Type
Figure 27. Sales Market Share of Celecoxib by Type (2020-2025)
Figure 28. Sales Market Share of Celecoxib by Type in 2025
Figure 29. Market Share of Celecoxib by Type (2020-2025)
Figure 30. Market Share of Celecoxib by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Celecoxib Market Share by Application
Figure 33. Global Celecoxib Sales Market Share by Application (2020-2025)
Figure 34. Global Celecoxib Sales Market Share by Application in 2025
Figure 35. Global Celecoxib Market Share by Application (2020-2025)
Figure 36. Global Celecoxib Market Share by Application in 2025
Figure 37. Global Celecoxib Sales Growth Rate by Application (2020-2025)
Figure 38. Global Celecoxib Sales Market Share by Region (2020-2025)
Figure 39. Global Celecoxib Market Size by Region (2020-2025)
Figure 40. North America Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Celecoxib Sales Market Share by Country in 2024
Figure 43. North America Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Celecoxib Market Size by Country in 2024
Figure 45. U.S. Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Celecoxib Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Celecoxib Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Celecoxib Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Celecoxib Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Celecoxib Sales Market Share by Country in 2024
Figure 53. Europe Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Celecoxib Market Size by Country in 2024
Figure 55. Germany Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Celecoxib Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Celecoxib Sales Market Share by Region in 2024
Figure 67. Asia Pacific Celecoxib Market Size by Region in 2024
Figure 68. China Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Celecoxib Sales and Growth Rate (K MT)
Figure 79. South America Celecoxib Sales Market Share by Country in 2024
Figure 80. South America Celecoxib Market Size and Growth Rate (M USD)
Figure 81. South America Celecoxib Market Size by Country in 2024
Figure 82. Brazil Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Celecoxib Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Celecoxib Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Celecoxib Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Celecoxib Market Size by Region in 2024
Figure 92. Saudi Arabia Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Celecoxib Production Market Share by Region (2020-2025)
Figure 103. North America Celecoxib Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Celecoxib Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Celecoxib Production (K MT) Growth Rate (2020-2025)
Figure 106. China Celecoxib Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Celecoxib Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Celecoxib Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Celecoxib Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Celecoxib Market Share Forecast by Type (2026-2035)
Figure 111. Global Celecoxib Sales Forecast by Application (2026-2035)
Figure 112. Global Celecoxib Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Celecoxib
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Celecoxib Market Size (M USD), 2025-2035
Figure 5. Global Celecoxib Market Size (M USD) (2020-2035)
Figure 6. Global Celecoxib Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Celecoxib Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Celecoxib Product Life Cycle
Figure 13. Celecoxib Sales Share by Manufacturers in 2025
Figure 14. Global Celecoxib Revenue Share by Manufacturers in 2025
Figure 15. Celecoxib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Celecoxib Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Celecoxib Revenue in 2025
Figure 18. Industry Chain Map of Celecoxib
Figure 19. Global Celecoxib Market PEST Analysis
Figure 20. Global Celecoxib Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Celecoxib Market Share by Type
Figure 27. Sales Market Share of Celecoxib by Type (2020-2025)
Figure 28. Sales Market Share of Celecoxib by Type in 2025
Figure 29. Market Share of Celecoxib by Type (2020-2025)
Figure 30. Market Share of Celecoxib by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Celecoxib Market Share by Application
Figure 33. Global Celecoxib Sales Market Share by Application (2020-2025)
Figure 34. Global Celecoxib Sales Market Share by Application in 2025
Figure 35. Global Celecoxib Market Share by Application (2020-2025)
Figure 36. Global Celecoxib Market Share by Application in 2025
Figure 37. Global Celecoxib Sales Growth Rate by Application (2020-2025)
Figure 38. Global Celecoxib Sales Market Share by Region (2020-2025)
Figure 39. Global Celecoxib Market Size by Region (2020-2025)
Figure 40. North America Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Celecoxib Sales Market Share by Country in 2024
Figure 43. North America Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Celecoxib Market Size by Country in 2024
Figure 45. U.S. Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Celecoxib Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Celecoxib Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Celecoxib Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Celecoxib Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Celecoxib Sales Market Share by Country in 2024
Figure 53. Europe Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Celecoxib Market Size by Country in 2024
Figure 55. Germany Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Celecoxib Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Celecoxib Sales Market Share by Region in 2024
Figure 67. Asia Pacific Celecoxib Market Size by Region in 2024
Figure 68. China Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Celecoxib Sales and Growth Rate (K MT)
Figure 79. South America Celecoxib Sales Market Share by Country in 2024
Figure 80. South America Celecoxib Market Size and Growth Rate (M USD)
Figure 81. South America Celecoxib Market Size by Country in 2024
Figure 82. Brazil Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Celecoxib Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Celecoxib Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Celecoxib Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Celecoxib Market Size by Region in 2024
Figure 92. Saudi Arabia Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Celecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Celecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Celecoxib Production Market Share by Region (2020-2025)
Figure 103. North America Celecoxib Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Celecoxib Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Celecoxib Production (K MT) Growth Rate (2020-2025)
Figure 106. China Celecoxib Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Celecoxib Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Celecoxib Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Celecoxib Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Celecoxib Market Share Forecast by Type (2026-2035)
Figure 111. Global Celecoxib Sales Forecast by Application (2026-2035)
Figure 112. Global Celecoxib Market Share Forecast by Application (2026-2035)
